PerkinElmer to buy cell engineering firm Horizon Discovery for $383m

This article was originally published here

The deal has a total enterprise value of around $368m. Based in Cambridge, Horizon Discovery offers CRISPR and RNAi reagents, cell models, cell engineering and base editing solutions

The post PerkinElmer to buy cell engineering firm Horizon Discovery for $383m appeared first on Pharmaceutical Business review.